Schedule 13G ownership disclosure

MERUS N V

Common Shares, (euro)0.09 nominal value per share · CUSIP: N5749R100

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Paradigm BioCapital Advisors LP

    Shares: 4,673,770.00 · Class: 6.2%

  • Paradigm BioCapital Advisors GP LLC

    Shares: 4,673,770.00 · Class: 6.2%

  • Senai Asefaw, M.D.

    Shares: 4,673,770.00 · Class: 6.2%

  • Paradigm BioCapital International Fund Ltd.

    Shares: 4,121,059.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-112622
Form type
SCHEDULE 13G/A
Filer
Merus N.V.
CIK
CIK 1651311
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub